While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

In a paper published in PNAS, researchers at King's College London and the University of Washington describe the unique 3D structure of this protein, which is now being used to develop cancer drug ...

Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells ...

A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that.

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one day, he thought it might effectively fight cancer. He was right, and he ...

Renato Aguilera, Ph.D., a professor of biological sciences at The University of Texas at El Paso, holds up a vial of pyronaridine, an anti-malarial drug that he recently patented for use in cancer ...